WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
Patient Spotlight: Prostate Cancer Survivor Robert Palmer Shares His Experience with Focused Ultrasound Treatment
With prostate cancer affecting 1 in 8 men, according to the American Cancer Society, many men worry about…
Read MoreRight Scan Right Time Joins Fellow Patient Groups in Urging Congress to Recognize Value of Artificial Intelligence (AI) in Medical Imaging
Right Scan Right Time, along with 14 other patient groups, recently sent a letter to congressional leaders highlighting…
Read MoreCongressional Briefing Discusses the Potential of Focused Ultrasound Therapy
With high incidences of neurologic conditions like chronic pain, childhood brain tumors, and mental illnesses, the need is…
Read MoreAdvocating for Equitable Access to AI in Healthcare During National Minority Health Month
Each April, National Minority Health Month reminds us of the importance of supporting policies that address healthcare disparities…
Read More